FOX CORP - CLASS A/ US35137L1052 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 18.46 bill.USD | 1.24% | 13.32 |
GlobeNewswire
10/06
The Portnoy Law Firm Announces Investigation of Fox Factory Holding Corp. (NASDAQ: FOXF)
GlobeNewswire
15/04
Fox Factory Holding Corp. investors: Please contact the Portnoy Law Firm to recover your losses; Apr...
GlobeNewswire
30/12/2023
Xponential Fitness Investor Alert: Kaplan Fox Investigates Potential Securities Fraud At Xponential
GlobeNewswire
17/12/2023
Kaplan Fox & Kilsheimer LLP Reminds Acelyrin Investors of a Class Action Lawsuit and Upcoming Deadli...
GlobeNewswire
17/12/2023
Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming D...
GlobeNewswire
13/12/2023
Acelyrin, Inc. Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Acelyrin Investors of a Class A...
GlobeNewswire
13/12/2023
Eagle Pharmaceuticals Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals In...
GlobeNewswire
09/12/2023
MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsui...
GlobeNewswire
08/12/2023
VERADIGM SHAREHOLDER UPDATE: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of Upcoming Dead...
GlobeNewswire
07/12/2023
CHPT Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies ChargePoint Investors of a Class Action La...
GlobeNewswire
07/12/2023
EGRX Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: E...
GlobeNewswire
07/12/2023
SLRN Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Acelyrin, Inc. (Nasdaq: SLRN)
GlobeNewswire
06/12/2023
VERADIGM INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Veradigm Investors of a Class Action L...
GlobeNewswire
06/12/2023
FISKER INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Fisker Investors of a Class Action Lawsu...
GlobeNewswire
04/12/2023
CHARGEPOINT INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies ChargePoint Investors of a Class Ac...
GlobeNewswire
04/12/2023
Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX)